URE

UREA

Created: 1999-07-08
Last modified:  2024-09-27

Find related ligands:

Chemical Details

Formal Charge0
Atom Count8
Chiral Atom Count0
Bond Count7
Aromatic Bond Count0
2D diagram of URE

Chemical Component Summary

NameUREA
Systematic Name (OpenEye OEToolkits)urea
FormulaC H4 N2 O
Molecular Weight60.055
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs10.04O=C(N)N
SMILESCACTVS3.341NC(N)=O
SMILESOpenEye OEToolkits1.5.0C(=O)(N)N
Canonical SMILESCACTVS3.341 NC(N)=O
Canonical SMILESOpenEye OEToolkits1.5.0 C(=O)(N)N
InChIInChI1.03 InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)
InChIKeyInChI1.03 XSQUKJJJFZCRTK-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB03904 
NameUrea
Groups
  • approved
  • investigational
DescriptionA compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids.
Synonyms
  • Carbamide
  • Urée
  • Carbonyldiamide
  • Urea
  • Karbamid
Brand Names
  • Urederm Cream 10%
  • Urea Cream 40 Percent
  • Keratol 40
  • Rynoderm
  • Ure-K
IndicationUrea is used topically for debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged, devitalized and ingrown nails.[L41484]
Categories
  • Amides
  • Blood and Blood Forming Organs
  • Blood Substitutes and Perfusion Solutions
  • Carbamide products
  • Dermatologicals
ATC-Code
  • D02AE01
  • B05BC02
  • D02AE51
CAS number57-13-6

Drug Targets

NameTarget SequencePharmacological ActionActions
Dihydrofolate reductaseVRSLNSIVAVCQNMGIGKDGNLPWPPLRNEYKYFQRMTSTSHVEGKQNAV...unknownactivator
Arginase-1MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDY...unknown
Carbonic anhydrase 2MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVS...unknown
Catenin beta-1MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKG...unknown
Sulfoxide reductase catalytic subunit YedYMKKNQFLKESDVTAESVFFMKRRQVLKALGISAAALSLPHAAHADLLSWF...unknown
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL985
PubChem 1176
ChEMBL CHEMBL985
ChEBI CHEBI:48376, CHEBI:16199
CCDC/CSD ACUFUR01, ACUYAY, BARBUR01, ACUYEC, AZUQAP, BARBUR02, BARBUR06, BARBUR03, BARBUR04, BARBUR05, BARBUR, AWISOO, ACUFUR, BAFTEH, BAQZOI, AMIMAK, AMILUD01, AMILUD, AMILEN, BAFSOQ, AWISUU, BAFWIO, AMILEN01, ARAMEO, AQUMIL01, AQUMIL
COD 2016711, 2016712, 1008775, 1008776, 1008786, 1008787, 2019369, 2311086, 1544223, 1544224, 1544225, 1544226, 2022025, 2003112